In the present study, we developed a prognostic and diagnostic biomarker with 5 selected MRGs (A2M, DUSP6, HLA-B, SERPINE2, and SLC26A2), all of which acted as risk factors in melanoma. Here, SLC26A2 is linked to melanoma.